XML 22 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1Close
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 3,194 $ 1,718
Accounts receivable, net of allowance of $129 in 2023 and $114 in 2022 2,690 2,571
Inventories 2,824 2,679
Prepaid expenses and other current assets 892 857
Current assets of discontinued operations 0 186
Total current assets 9,600 8,011
Property, plant and equipment, net 4,433 4,695
Goodwill 6,514 6,452
Other intangible assets 6,079 6,793
Operating lease right-of-use assets 524 541
Other non-current assets 1,126 1,109
Non-current assets of discontinued operations 0 686
Total assets 28,276 28,287 Close
Current liabilities:    
Short-term debt 0 299
Current maturities of long-term debt and finance lease obligations 2,668 1,105
Accounts payable 1,241 1,110
Accrued expenses and other current liabilities 2,594 2,170
Current liabilities of discontinued operations 0 61
Total current liabilities 6,503 4,745
Long-term debt and finance lease obligations 11,130 15,232
Operating lease liabilities 438 447
Other non-current liabilities 1,737 1,848
Non-current liabilities of discontinued operations 0 120
Total liabilities 19,808 22,392 Close
Commitments and contingencies
Equity:    
Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2023 and 2022 683 683
Common stock in treasury, at cost, 175,861,893 shares in 2023 and 179,062,594 shares in 2022 (11,230) (11,389)
Additional contributed capital 6,389 6,322
Retained earnings 16,114 14,050
Accumulated other comprehensive income (loss) (3,554) (3,833)
Total Baxter stockholders’ equity 8,402 5,833
Noncontrolling interests 66 62
Total equity 8,468 5,895 Close
Total liabilities and equity $ 28,276 $ 28,287